Deleting TCR alpha beta+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice.
about
The influence of innate and adaptive immune responses on atherosclerosisAdaptive immunity and atherosclerosis: mouse tales in the AJPInhaled asbestos exacerbates atherosclerosis in apolipoprotein E-deficient mice via CD4+ T cellsInterleukin 17 in vascular inflammation.The atheroprotective effect of 17beta-estradiol depends on complex interactions in adaptive immunityInnate and adaptive immunity in atherosclerosis.CD8+ T cell activation predominate early immune responses to hypercholesterolemia in Apoe⁻(/)⁻ mice.TAP1-deficiency does not alter atherosclerosis development in Apoe-/- mice.γδT cells are prevalent in the proximal aorta and drive nascent atherosclerotic lesion progression and neutrophilia in hypercholesterolemic mice.Agonistic anti-TIGIT treatment inhibits T cell responses in LDLr deficient mice without affecting atherosclerotic lesion developmentLymphocyte migration into atherosclerotic plaque.PD-1 and Tim-3 Pathways Regulate CD8+ T Cells Function in AtherosclerosisGammadelta (γδ) T lymphocytes do not impact the development of early atherosclerosis.Animal models of atherosclerosis.Thematic review series: the immune system and atherogenesis. The unusual suspects:an overview of the minor leukocyte populations in atherosclerosis.Ablation of CD8α(+) dendritic cell mediated cross-presentation does not impact atherosclerosis in hyperlipidemic mice.Adaptive immunity in atherogenesis: new insights and therapeutic approaches.Understanding the oestrogen action in experimental and clinical atherosclerosis.Immune and inflammatory mechanisms of atherosclerosis (*)Timing of estrogen replacement influences atherosclerosis progression and plaque leukocyte populations in ApoE-/- mice.Vaccination against atherosclerosis? Induction of atheroprotective immunity.Inflammation and immune system interactions in atherosclerosis.Vaccines against atherosclerosis.Molecular biology of atherosclerosis.Macrophages and immune cells in atherosclerosis: recent advances and novel concepts.Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential.Protective and pathogenic roles of CD8(+) T cells in atherosclerosis.The immunology of atherosclerosis.Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges.Association between CD8+ T-cell subsets and cardiovascular disease.Deep sequencing of the T cell receptor β repertoire reveals signature patterns and clonal drift in atherosclerotic plaques and patients.Anti-atherosclerotic effect of the angiotensin 1-7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis.Posttransplant Immune Activation: Innocent Bystander or Insidious Culprit of Posttransplant Accelerated Atherosclerosis.Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis.T lymphocyte autoreactivity in inflammatory mechanisms regulating atherosclerosisEvaluation of CD25+CD4+ Regulatory T-Lymphocyte Subpopulations in Coronary Artery Diseases Patients
P2860
Q27000370-4C962899-FD63-48B3-9582-1E34D30B949EQ27023345-567F56D7-C2F9-4BAA-B775-81E55C88054DQ28385653-CFBA8452-7B7E-4230-BCBC-2EDA0420EABBQ30429445-8B277DA2-733B-4752-8E45-84F24737B62BQ30478113-30BA62BD-3F89-4A0B-B195-83A40E80FAAFQ33659705-E52FE5AE-3850-43BD-8F11-56545E7431F8Q33761718-B38431AE-20DA-4F81-81DD-CC8180048B3FQ34221791-AD1244B9-8C97-4485-996B-30FACFD7601AQ34337885-3EA619CD-AA08-4407-9583-C9B2A2CA22D4Q35077942-AB641A28-24EF-4ACD-8440-910B2C401907Q35600904-10E091AD-2051-4E73-90B6-45DE1F45F339Q35649732-B197FA85-182F-4201-B577-FA1EE878B4B3Q35748386-500D42CC-D2D6-4C32-BA7F-7E5B7FC0E4F3Q35903298-05B11EB3-6276-4895-9246-161BD1171178Q36072740-D16528B5-C3AC-4825-B02E-6834772B2CEEQ36186394-1C2E3182-EDDD-484B-9F1B-957A814A7186Q36497196-070D96CE-00AF-4F67-84F2-C27CDCCD96BBQ36655236-3CDC6D20-13C8-47B1-9B5C-E2BEFA22B9B6Q37325024-9C1148C7-52F0-4C62-8C35-0BD3DB02EB1EQ37438247-D96E1DA0-52BE-4290-8A0B-A16776B1C646Q37495603-214428EF-C8EA-4C2D-A761-9970AF794DBBQ38083555-28B8F33D-7527-48E7-8998-48193B4229FEQ38089941-1E945E51-6988-415F-91AC-A0075458A19DQ38125279-30F9A630-92AA-4786-84DE-7C81B17FA831Q38462573-2F3D9534-F3C4-4B78-B830-039FC9983364Q38620803-3719221A-11D9-4A8D-BB3C-D72A752ADF14Q38991262-B84D3B35-45E5-400C-806D-6D286B053A0CQ39230390-3146260A-656F-4DDA-B98E-30B4947B3876Q39283173-20D14242-D51C-47EA-BA82-BF83D3469999Q45935461-F2537A82-646E-43D4-A872-119D439A42C5Q47094217-2953006A-1950-4F04-BDF3-E405FF1DA790Q47104825-E0F163DF-F923-493B-BCEE-E2B4D5F09316Q47119851-8D55A537-8B41-424B-9F38-89A7205B842DQ51830691-719EA611-7FB9-4493-8A39-31BE8F1ACBF0Q58914607-248EE006-5DB1-43FA-A7C5-056B7D2B1DCBQ59047881-84E6C5F2-871D-4DEE-9850-D68FB9543802
P2860
Deleting TCR alpha beta+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice.
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Deleting TCR alpha beta+ or CD ...... olipoprotein E-deficient mice.
@ast
Deleting TCR alpha beta+ or CD ...... olipoprotein E-deficient mice.
@en
type
label
Deleting TCR alpha beta+ or CD ...... olipoprotein E-deficient mice.
@ast
Deleting TCR alpha beta+ or CD ...... olipoprotein E-deficient mice.
@en
prefLabel
Deleting TCR alpha beta+ or CD ...... olipoprotein E-deficient mice.
@ast
Deleting TCR alpha beta+ or CD ...... olipoprotein E-deficient mice.
@en
P2093
P2860
P1476
Deleting TCR alpha beta+ or CD ...... olipoprotein E-deficient mice.
@en
P2093
Catherine Fiévet
Francis Bayard
Jacek Jawien
Jean Claude Couloumiers
Jean-François Arnal
Laurent Brouchet
Marie-José Fouque
Pierre Gourdy
Rima Elhage
Xavier Huc
P2860
P304
P356
10.1016/S0002-9440(10)63252-X
P407
P577
2004-12-01T00:00:00Z